1. 上海中医药大学附属曙光医院肿瘤科、肿瘤研究所,上海,201203
2. 上海中医药大学附属市中医医院肿瘤科,上海,200071
扫 描 看 全 文
周利红, 王婷, 韩植芬, 等. 大肠癌血瘀证与非血瘀证患者肿瘤组织血管新生标记物、HIF-1α和VEGF表达的差异性[J]. 上海中医药杂志, 2019,53(10):28-32.
ZHOU Lihong, WANG Ting, HAN Zhifen, et al. Differences on expressions of angiogenenic markers, HIF-1α and VEGF in tumor tissue of colorectal cancer patients with blood stasis syndrome or non-blood stasis syndrome[J]. Shanghai Journal of Traditional Chinese Medicine, 2019,53(10):28-32.
周利红, 王婷, 韩植芬, 等. 大肠癌血瘀证与非血瘀证患者肿瘤组织血管新生标记物、HIF-1α和VEGF表达的差异性[J]. 上海中医药杂志, 2019,53(10):28-32. DOI: 10.16305/j.1007-1334.2019.10.007.
ZHOU Lihong, WANG Ting, HAN Zhifen, et al. Differences on expressions of angiogenenic markers, HIF-1α and VEGF in tumor tissue of colorectal cancer patients with blood stasis syndrome or non-blood stasis syndrome[J]. Shanghai Journal of Traditional Chinese Medicine, 2019,53(10):28-32. DOI: 10.16305/j.1007-1334.2019.10.007.
目的:通过检测大肠癌血瘀证与非血瘀证患者肿瘤组织的血管新生标记物、缺氧诱导因子-1α(HIF-1α)和血管内皮生长因子(VEGF)的表达情况,分析大肠癌血瘀证与肿瘤血管新生之间的关系。 方法:将116例(均为回顾性病例)临床大肠癌患者分为血瘀证组与非血瘀证组,采用免疫组织化学技术检测肿瘤组织中的血管新生肿瘤标记和HIF-1α和VEGF的阳性表达情况,结合临床分期分析大肠癌血瘀证与非血瘀证患者上述指标表达的差异性。 结果:①大肠癌血瘀证与非血瘀证患者的临床分期以Ⅱa期和Ⅲb期为主,差异无统计学意义(P>0.05);②大肠癌血瘀证与非血瘀证患者肿瘤组织血管CD34的阳性表达差异有统计学意义(P<0.001),CK-7、CK-20、CEA、CDX-2、p53、Ki-67、神经S-100、淋巴管D2-40的阳性表达差异无统计学意义(P>0.05);③大肠癌血瘀证患者肿瘤组织HIF-1α和VEGF的阳性表达高于大肠癌非血瘀证患者(P<0.001)。 结论:大肠癌血瘀证患者肿瘤血管CD34、HIF-1α和VEGF的阳性表达明显高于非血瘀证患者,提示大肠癌血瘀证与肿瘤血管新生密切相关。
Objective:To detect the expression levels of angiogenic tumor markers, hypoxia inducible factor-1α(HIF-1α) and vascular endothelial growth factor (VEGF) in tumor tissue of colorectal cancer patients with blood stasis syndrome or non-blood stasis syndrome, and analysis the relationship between blood stasis syndrome and tumor angiogenesis. MethodsOne hundred and sixteen patients (retrospective cases) were divided into the blood stasis syndrome group and non-blood stasis syndrome group. The positive expressions of angiogenic tumor markers, HIF-1α and VEGF in tumor tissue were measured by immunohistochemistry, and combined with clinical stages, the differences on the expressions of above indicators in colorectal cancer patients with blood stasis syndrome or non-blood stasis syndrome were analyzed. Results:① The clinical stages of colorectal cancer patients with blood stasis syndrome or non-blood stasis syndrome were mainly stage Ⅱa and stage Ⅲb, and there was no statistical significance between the two groups (P>0.05). ② There was statistically significant difference on the positive expression of vascular CD34 in tumor tissue between colorectal cancer patients with blood stasis syndrome and those patients with non-blood stasis syndrome(P<0.001), but there were no statistically significant differences on the positive expressions of CK-7, CK-20, CEA, CDX-2, p53, Ki-67, nerve S-100 and lymphatic D2-40 (P>0.05). ③ The positive expressions of HIF-1α and VEGF in tumor tissue of colorectal cancer patients with blood stasis syndrome were significantly higher than those of colorectal cancer patients with non-blood stasis syndrome (P<0.001). Conclusion:Compared with colorectal cancer patients with non-blood stasis syndrome, the positive expressions of CD34, HIF-1α and VEGF in tumor are significantly increased in patients with blood stasis syndrome, which suggests that blood stasis syndrome of colorectal cancer is closely related to tumor angiogenesis.
大肠癌血瘀证血管新生缺氧诱导因子-1α血管内皮生长因子
0
浏览量
402
下载量
0
CSCD
16
CNKI被引量
关联资源
相关文章
相关作者
相关机构